K. S. R. Pai, “Molecular docking and simulation studies of FDA approved drugs targeting Allosteric inhibition of Glycogen synthase kinase-3β ”, Jordan j. pharm. sci., vol. 19, no. 1, pp. 52–70, Mar. 2026.